Main Types: HTLV-1 and HTLV-2
Within the family of human T-lymphotropic viruses, two types are the most thoroughly studied, differing in their group-specific antigens and associated pathologies.
- HTLV-1 was first isolated in 1980 from T-cell lymphoma cells. Its primary role in human pathology is causing Adult T-cell leukemia/lymphoma (ATLL).
- HTLV-2 possesses different group-specific antigens distinguishing it from type 1. This variant was first isolated from a patient with hairy cell leukemia.
Unique Genetic Features
A crucial distinction of HTLV from many other oncogenic viruses lies in its genome structure. The viral apparatus contains two additional unique regulatory genes — tax and rex — which play a key role in the pathogen's life cycle and malignant cellular transformation.
- The tax gene and its product: Acts as a potent transactivator. The protein encoded by the tax gene directly targets the long terminal repeats (LTRs) in the viral genome, stimulating viral mRNA transcription. Furthermore, this product induces the formation of specific interleukin-2 (IL-2) receptors on the infected host cell membrane, triggering uncontrolled cell proliferation (division).
- The rex gene and its product: Performs a strictly regulatory function. The product of this gene controls the sequence and proper timing of viral mRNA translation, ensuring correct assembly of viral components.
Epidemiology and Transmission Routes
Despite the severity of the diseases they cause, the epidemiology of these viruses remains under-investigated globally. Distinct endemic zones exist where the infection is most prevalent: the Sahara Desert region, the Caribbean, and southern Japan.
Transmission occurs via several routes, making the epidemiology of HTLV similar to HIV:
- Sexual transmission — via unprotected sexual contact.
- Transfusion transmission — spread through blood and blood products (e.g., transfusion of infected components).
- Vertical (transplacental) transmission — transmission from an infected mother to the fetus during pregnancy or breastfeeding.
Pathogenesis and Diagnostics
Both virus types (HTLV-1 and HTLV-2) share common pathogenic features. Notably, they exhibit a striking resemblance to the Human Immunodeficiency Virus (HIV), as the primary target for HTLV is also the immune system.
The infectious process is characterized by:
- A prolonged incubation period, which can last up to 20 years from initial infection.
- Slow, relentless progression of the disease after symptom onset.
- Fatal outcomes characteristic of advanced leukemia/lymphoma stages.
Currently, specific prophylaxis (vaccines) and targeted treatments are unavailable. Baseline laboratory diagnosis relies on detecting specific antibodies against the virus in the patient's serum.